Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
Introduction: Cardiotoxicity is one of the leading causes of compound attrition during drug development. Most in vitro screening platforms aim at detecting acute cardio-electrophysiological changes and drug-induced chronic functional alterations are often not studied in the early stage of drug devel...
Saved in:
Main Authors: | C. Altrocchi (Author), K. Van Ammel (Author), M. Steemans (Author), M. Kreir (Author), F. Tekle (Author), A. Teisman (Author), D. J. Gallacher (Author), H. R. Lu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation
by: Arie O. Verkerk, et al.
Published: (2021) -
Esophageal Cancer-Related Gene-4 Contributes to Lipopolysaccharide-Induced Ion Channel Dysfunction in hiPSC-Derived Cardiomyocytes
by: Xu Q, et al.
Published: (2024) -
In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes
by: Mohamadamin Forouzandehmehr, et al.
Published: (2024) -
Considerations in hiPSC-derived cartilage for articular cartilage repair
by: Akihiro Yamashita, et al.
Published: (2018) -
Human Cardiac Fibroblast Number and Activation State Modulate Electromechanical Function of hiPSC-Cardiomyocytes in Engineered Myocardium
by: Cassady E. Rupert, et al.
Published: (2020)